Results 91 to 100 of about 17,815 (221)

HIV-Associated Progressive Multifocal Leukoencephalopathy: A Case Study

open access: yesActa Medica Indonesiana, 2023
Progressive multifocal leukoencephalopathy (PML) is a rare, life-threatening, infectious, lytic, demyelinating disease that results from reactivation of the virulent JC polyomavirus (JCV) “major opportunistic infection” in immunosuppressed individuals ...
Elsayed Abed   +10 more
doaj   +2 more sources

Leucoencefalopatia cística sem megalencefalia [PDF]

open access: yes, 2008
UNIFESP-EPM Department of PediatricsFederal University of São Paulo Department of Neurology and Neurosurgery Division of Child NeurologyHospital Heliopolis Department of RadiologyFederal University of São Paulo EPM Department of Neurology and ...
Arita, Juliana Harumi   +5 more
core   +2 more sources

Multifocal Leukoencephalopathy

open access: yesPediatric Neurology Briefs, 1994
A 15-year-old boy with Wiskott-Aldrich syndrome complicated by progressive multifocal leukoencephalopathy (PML) is reported from the University of Miami School of Medicine, FL, and the National Institute of Neurological Disorders and Stroke, Bethesda, MD.
J Gordon Millichap
doaj   +1 more source

Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1 [PDF]

open access: yes, 2017
Progressive multifocal leukoencephalopathy is a currently untreatable infection of the brain. Here, we demonstrate in 2 patients that treatment with interleukin 7, JC polyomavirus (JCV) capsid protein VP1, and a Toll-like receptor 7 agonist used as ...
Bofill-Mas, Silvia   +12 more
core  

Interventions for neurocognitive dysfunction [PDF]

open access: yes, 2017
Purpose of review: To evaluate current barriers to HIV cure strategies and interventions for neurocognitive dysfunction with a particular focus on recent advancements over the last three years. Recent findings: Optimal anti-retroviral therapy (ART) poses
Brew, B, Ellero, J, Lubomski, M
core   +2 more sources

Clinical perspectives of emerging pathogens in bleeding disorders. [PDF]

open access: yes, 2006
As a result of immunological and nucleic-acid screening of plasma donations for transfusion-transmissible viruses, and the incorporation of viral reduction processes during plasma fractionation, coagulation-factor concentrates (CFC) are now judged safe ...
Bozzette, Samuel   +11 more
core   +1 more source

Peripheral blood biomarkers in multiple sclerosis. [PDF]

open access: yes, 2015
Multiple sclerosis is the most common autoimmune disorder affecting the central nervous system. The heteroge-neity of pathophysiological processes in MS contributes to the highly variable course of the disease and unpre-dictable response to therapies ...
Acheson   +298 more
core   +1 more source

Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown

open access: yesEye and Brain, 2017
Heather E Moss1,2 1Department of Ophthalmology, Stanford University, Palo Alto, CA, USA; 2Department of Neurology & Neuroscience, Stanford University, Stanford, CA, USA Abstract: Multiple sclerosis (MS) is associated with vision changes both due to ...
Moss HE
doaj  

Natalizumab therapy, 2013 [PDF]

open access: yes, 2014
Multiple sclerosis (MS) is the most common chronic disease of the central nervous system in young adults. No curative therapy is known. Currently, six drugs are available that can reduce the activity of MS.
Bencsik, Krisztina   +2 more
core  

A rare case of progressive multifocal leukoencephalopathy

open access: yesRadiology Case Reports
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system (CNS) due to John Cunningham (JC) virus reactivation most often in immunocompromised patients.
Jayanthraj Gone, DO   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy